Study of the Prevalence of Cosavirus and Salivirus Infections, Two New Genera of Picornaviridae, In Infants
NCT ID: NCT02862847
Last Updated: 2016-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
615 participants
OBSERVATIONAL
2015-07-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To date, no study on these two viruses has been conducted in France to evaluate the circulation and the pathogenicity of these viruses in subjects with diarrhoea.
The aim of this study is thus to:
* show that these viruses are in circulation in France in infants younger than 5 years old and that the proportions are similar to those reported in the literature.
* confirm the relationship between the diarrhoea and the infection with these viruses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Human Cytomegalovirus in the Saliva
NCT00815802
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
NCT01923636
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
NCT05754879
Zika in Infants and Pregnancy (ZIP)
NCT02856984
Pilot Study to Detect Zika Virus in Sperm
NCT02874456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
gastroenteritis
stool samples
control
stool samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stool samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children hospitalized or consulting at Dijon CHU during the 12 months of the study for acute gastroenteritis. Acute gastroenteritis is defined by at least 3 soft or liquid stools or at least 3 bouts of vomiting within 24 hours or signs (diarrhoea or vomiting) accompanied by at least 2 additional symptoms among diarrhoea or vomiting, abdominal pain, fever
for controls
* Children younger than 5 years old
Exclusion Criteria
* Children older than 5 years.
* Children presenting chronic diarrhoea (\> 2 weeks) (e.g. Crohn and UC)
* Children with immune deficiency.
* Children with nosocomial gastroenteritis; the nosocomial aspect will be defined as the onset of acute diarrhoea occurring after the 48th hour after admission
for controls
* Persons without national health insurance cover
* Children older than 5 years.
* Children with chronic diarrhoea (\> 2 weeks) (e.g. Crohn and UC)
* Children with immune deficiency.
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DE ROUGEMONT AOI 2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.